Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ETHZilla Corp Director's Dealing 2021

Dec 10, 2021

33039_dirs_2021-12-10_41bcb3fd-dc53-4ea4-9e56-4387dc3bcfca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2021-12-08

Reporting Person: Rothbard Jonathan B. (Chief Scientific Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-08 Stock Option (Right to Buy) $3.95 A 300000 Acquired 2031-12-08 Common Stock (300000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 560449 Direct

Footnotes

F1: The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as Chief Scientific Officer. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.

F2: The options vest at the rate of 1/3rd of such options at the date of grant with the remaining options vesting at the rate of 24 equal monthly installments, beginning on the last day of December 31, 2021, and continuing on the last day of each calendar month thereafter, subject to the Reporting Person's continued service to the Company on such vesting dates.